New Peer-Reviewed Published Data is Now Available on VeriStrat

biodesix
  • Amanda Bridges
  • December 10, 2016

The study on VeriStrat was published in the British Journal of Cancer and validates the prognostic value and utility of VeriStrat in patients diagnosed with non-small cell lung cancer (NSCLC) in the front line setting. Follow this link to view publication.
Brought to you by Biodesix

© 2021 FLASCO | Premium Website Design by The HDG

FLASCO